These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1000 related articles for article (PubMed ID: 22992469)

  • 1. Chronic kidney disease alters intestinal microbial flora.
    Vaziri ND; Wong J; Pahl M; Piceno YM; Yuan J; DeSantis TZ; Ni Z; Nguyen TH; Andersen GL
    Kidney Int; 2013 Feb; 83(2):308-15. PubMed ID: 22992469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Different Hemodialysis Methods on Microbiota in Uremic Patients.
    He H; Xie Y
    Biomed Res Int; 2020; 2020():6739762. PubMed ID: 32685517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacterial populations of the small intestine in uremia.
    Simenhoff ML; Saukkonen JJ; Burke JF; Wesson LG; Schaedler RW; Gordon SJ
    Nephron; 1978; 22(1-3):63-8. PubMed ID: 745639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liquid Chromatography/Mass Spectrometry Reveals the Effect of Lactobacillus Treatment on the Faecal Metabolite Profile of Rats with Chronic Renal Failure.
    Wu B; Jiang H; He Q; Wang M; Xue J; Liu H; Shi K; Wei M; Liang S; Zhang L
    Nephron; 2017; 135(2):156-166. PubMed ID: 27889756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expansion of urease- and uricase-containing, indole- and p-cresol-forming and contraction of short-chain fatty acid-producing intestinal microbiota in ESRD.
    Wong J; Piceno YM; DeSantis TZ; Pahl M; Andersen GL; Vaziri ND
    Am J Nephrol; 2014; 39(3):230-237. PubMed ID: 24643131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo assessment of intraintestinal bacteriotherapy in chronic kidney disease.
    Ranganathan N; Patel BG; Ranganathan P; Marczely J; Dheer R; Pechenyak B; Dunn SR; Verstraete W; Decroos K; Mehta R; Friedman EA
    ASAIO J; 2006; 52(1):70-9. PubMed ID: 16436893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The intestinal microbiota, a leaky gut, and abnormal immunity in kidney disease.
    Anders HJ; Andersen K; Stecher B
    Kidney Int; 2013 Jun; 83(6):1010-6. PubMed ID: 23325079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic kidney disease and the gut microbiome.
    Hobby GP; Karaduta O; Dusio GF; Singh M; Zybailov BL; Arthur JM
    Am J Physiol Renal Physiol; 2019 Jun; 316(6):F1211-F1217. PubMed ID: 30864840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered intestinal microbial flora and impaired epithelial barrier structure and function in CKD: the nature, mechanisms, consequences and potential treatment.
    Vaziri ND; Zhao YY; Pahl MV
    Nephrol Dial Transplant; 2016 May; 31(5):737-46. PubMed ID: 25883197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Leaky Gut and Altered Microbiome in Chronic Kidney Disease.
    Lau WL; Vaziri ND
    J Ren Nutr; 2017 Nov; 27(6):458-461. PubMed ID: 29056165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterisation of the faecal metabolome and microbiome of Thoroughbred racehorses.
    Proudman CJ; Hunter JO; Darby AC; Escalona EE; Batty C; Turner C
    Equine Vet J; 2015 Sep; 47(5):580-6. PubMed ID: 25041526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Microecological disorders in the intestines of patients with chronic kidney failure and the arterial hypertension syndrome].
    Bobrov VA; Karpov PF
    Ter Arkh; 1993; 65(6):41-3. PubMed ID: 8378848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Studies of changes in human intestinal micro-biocenosis in health and in disease].
    Nesvizhkiĭ IuV
    Vestn Ross Akad Med Nauk; 2003; (1):49-53. PubMed ID: 12608086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut bacterial translocation is associated with microinflammation in end-stage renal disease patients.
    Wang F; Jiang H; Shi K; Ren Y; Zhang P; Cheng S
    Nephrology (Carlton); 2012 Nov; 17(8):733-8. PubMed ID: 22817644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The microbiome of New World vultures.
    Roggenbuck M; Bærholm Schnell I; Blom N; Bælum J; Bertelsen MF; Sicheritz-Pontén T; Sørensen SJ; Gilbert MT; Graves GR; Hansen LH
    Nat Commun; 2014 Nov; 5():5498. PubMed ID: 25423494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased hepatic insulin-like growth factor (IGF)-I and increased IGF binding protein-1 and -2 gene expression in experimental uremia.
    Tönshoff B; Powell DR; Zhao D; Durham SK; Coleman ME; Domené HM; Blum WF; Baxter RC; Moore LC; Kaskel FJ
    Endocrinology; 1997 Mar; 138(3):938-46. PubMed ID: 9048593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Urotoxic effect to intestinal bacteria in patients with chronic renal failure].
    Chen L; Jiang Y; Luo J
    Hunan Yi Ke Da Xue Xue Bao; 1999; 24(2):183-5. PubMed ID: 11938787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonextracorporeal methods for decreasing uremic solute concentration: a future way to go?
    Meijers B; Glorieux G; Poesen R; Bakker SJ
    Semin Nephrol; 2014 Mar; 34(2):228-43. PubMed ID: 24780475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progressive accumulation of lanthanum in the liver of normal and uremic rats.
    Slatopolsky E; Liapis H; Finch J
    Kidney Int; 2005 Dec; 68(6):2809-13. PubMed ID: 16316357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.